Armata Pharmaceuticals, Inc.
ARMPDrugs in Pipeline
7
Phase 3 Programs
0
Upcoming Catalysts
1
Next Catalyst
Aug 11, 2026
13dMarket Overview
Stock performance and key metrics
1 upcoming, 0 past
ARMP Earnings Report
EPS Est: $-0.48 | FQ end 2026-06
How ARMP's past catalysts played out
C16G2 Gel
Dental Caries
C16G2
Dental Caries
AP-PA02
Non-cystic Fibrosis Bronchiectasis
C16G2 Varnish
Dental Caries
C16G2 Rinse
Dental Caries
C16G2 Strip
Dental Caries
AP-SA02
Bacteremia
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
C16G2 Gel | Phase 2 | Dental Caries | - | - |
C16G2 | Phase 2 | Dental Caries | - | - |
AP-PA02 | Phase 2 | Non-cystic Fibrosis Bronchiectasis | - | - |
C16G2 Varnish | Phase 2 | Dental Caries | - | - |
C16G2 Rinse | Phase 2 | Dental Caries | - | - |
C16G2 Strip | Phase 2 | Dental Caries | - | - |
AP-SA02 | Phase 2 | Bacteremia | - | - |
Dental Caries
5 drugs in this indication
Non-cystic Fibrosis Bronchiectasis
1 drug in this indication
Bacteremia
1 drug in this indication
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Full breakdown — the signals behind the verdict
Frequently asked questions
What is in Armata Pharmaceuticals, Inc.'s drug pipeline?→
CatalystAlert tracks 7 drug candidates in Armata Pharmaceuticals, Inc.'s (ARMP) pipeline across Phase 2. Its lead program is C16G2 Gel (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Armata Pharmaceuticals, Inc.'s next FDA catalyst?→
Armata Pharmaceuticals, Inc.'s (ARMP) next tracked catalyst is a Earnings expected August 11, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track ARMP biotech catalysts?→
Add ARMP to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Armata Pharmaceuticals, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.